Streptococcus suis vaccines and diagnostic tests

Details Streptococcus suis vaccines and diagnostic tests Streptococcus suis vaccines and diagnostic tests

2006-10-24

2006-10-24

Duffy, Patricia A. (Department: 1645)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C424S093440, C424S200100, C424S244100, C435S252300, C435S253400

Reexamination Certificate

active

07125548

ABSTRACT:
The invention relates toStreptococcus suisinfection in pigs, vaccines directed against those infections and tests for diagnosingStreptococcus suisinfections. The invention provides an isolated or recombinant nucleic acid encoding a capsular gene cluster ofStreptococcus suisor a gene or gene fragment derivated thereof. The invention further provides a nucleic acid probe or primer allowing species or serotype-specific detection ofStreptococcus suis. The invention also provides aStreptococcus suisantigen and vaccine derived thereof.

REFERENCES:
patent: 5610011 (1997-03-01), Smith et al.
patent: 5681570 (1997-10-01), Yang et al.
patent: 5733765 (1998-03-01), Mollet et al.
patent: 5786184 (1998-07-01), Mollet et al.
patent: 5928900 (1999-07-01), Masure et al.
patent: 5948900 (1999-09-01), Yother et al.
patent: 5981229 (1999-11-01), Masure et al.
patent: WO 92/16630 (1992-10-01), None
patent: WO 92/21465 (1992-12-01), None
patent: WO 95/06732 (1995-03-01), None
patent: WO 95/31548 (1995-11-01), None
patent: WO 96/21465 (1996-07-01), None
patent: WO 00/05378 (2000-02-01), None
patent: WO 02/038597 (2002-05-01), None
patent: WO 02/061070 (2002-08-01), None
Ellis, R.W. (Chapter 29 of “VACCINES” Plotkin, S.A. et al. (eds) published by W. B. Saunders company (Philadelphia) in 1988, especially p. 571.
Herbert et al eds, The Dictionary of Immunology, Academic Press, 1995.
Gottschalk et al (Journal of Clinical Microbiology, 37(12):4242, Dec. 1999).
Segura et al (FEMS Immunology and Medical Microbiology 12:189-195, 1998).
Reams et al (J Vet. Diagn Invest 8:119-121, 1996).
Staats et al (Veterinary Research Communications, 21:381-407, 1997).
Brazeau et al, (Microbiology, 142:1231-1237, 1996).
PCT International Preliminary Examination Report, PCT/NL99/00460, dated Oct. 27, 2000.
PCT International Search Report, PCT/NL99/00460, dated Apr. 5, 2000, 6 pages.
Busque et al., Immunization of pigs againstStreptococcus suisserotype 2 infection using a live avirulent strain, Can J Vet Res., Oct. 1997, pp. 275-279, vol. 61, No. 4.
Charland et al.,Streptococcus suisserotype 2 mutants deficient in capsular expression, Microbiology, Feb. 1998, pp. 325-332, vol. 144, No. 2.
Elliott et al., Streptococcal infection in young pigs. V. An immunogenic polysaccharide fromStreptoccoccus suistype 2 with particular reference to vaccination against streptococcal meningitis in pigs, Oct. 1980, pp. 275-285, vol. 85, No. 2.
Kolkman et al., Diversity of capsular polysaccharide synthesis gene clusters inStreptococcus pneumoniae, J. Biochem., May 1998, pp. 937-945, vol. 123, No. 5.
Quessy et al., Immunization of mice againstStreptococcus suisserotype 2 infections using a live avirulent strain, Can. J. Vet Res., Oct. 1994, pp. 299-301, vol. 58, No. 4.
Roberts et al., The biochemistry and genetics of capsular polysaccharide production in bacteria, Ann. Rev. Microbiol., 1996, pp. 285-315, vol. 50.
Smith et al., Identification and characterization of the cps locus ofStreptococcus suisserotype 2: the capsule protects against phagocytosis and is an important virulence factor, Infect Immun., Apr. 1999, pp. 1750-1756, vol. 67, No. 4.
Smith et al., High efficiency transformation and gene inactivation inStreptococcus suistype 2, Microbiology, Jan. 1995, pp. 181-188, vol. 141.
Watson et al., Pneumococcal Virulence Factors and Host Immune Responses to Them, European Journal of Clinical Microbiology & Infectious Diseases, Jun. 1995, pp. 479-490, vol. 14, No. 6.
Smith et al., Cloning and nucleotide sequence of the gene encoding the 136-kilodalton surface protein (muramidase-released protein) ofStreptococcus suistype 2, Infection and Immunity, 1992, pp. 2361-2367, vol. 60, No. 6.
Smith et al., Repeats in an extracellular protein of weakly pathogenic strains ofStreptococcus suistype 2 are absent in pathogenic strains, Infection and Immunity, 1993, pp. 3318-3326, vol. 61, No. 8.
Smith et al., The cps locus ofStreptococcus suisserotype 2: genetic determinant for the synthesis of sialic acid, Microbial Pathogenesis, 2000, pp. 127-134, vol. 29, No. 2.
Smith et al., Selection of virulence-associated determinants ofStreptococcus suisserotype 2 by in vivo complementation, Infection and Immunity, Mar. 2001, pp. 1961-1966, vol. 69, No. 3.
Allgaier et al., Relatedness ofStreptococcus suisisolates of various serotypes and clinical backgrounds as evaluated by macrorestriction analysis and expression of potential virulence traits. Journal of Clinical Microbiology, 2001, pp. 445-453, vol. 39, No. 2.
Wisselink et al., Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant ofStreptococcus suisserotype 2, Veterinary Microbiology, 2002, pp. 155-168, vol. 84.
Merriam-Webster Online Dictionary, (visited Jun. 7, 2004) <http://www.m-w.com/cgi-bin/dictionary?book=Dictionary&va=vaccine&x=19&y=12>.
Database EMBL ‘Online’ McNab, S. gordonii partial aldB gene, cshA gene & fbpA gene, Database accession No. X65164, XP002213089.
De Greeff et al., Contribution of Fibronectin-Binding Protein to Pathogenesis ofStreptococcus suisSerotype 2, Infection and Immunity, Mar. 2002, pp. 1319-1325, vol. 70, No. 3.
De Greeff et al., Distribution of Environmentally Regulated Genes ofStreptococcus suisSerotype 2 amongS. suisSerotypes and Other Organisms, Journal of Clinical Microbiology, Sep. 2002, pp. 3261-3268, vol. 40, No. 9.
Kawabata et al., Molecular cloning, sequence and characterization of a novel streptococcal phosphoglycerate dehydrogenase gene, Oral Microbiology and Immunology, 2000, pp. 58-62, vol. 15.
Koskiniemi et al., Identification of two genes, cpsX and cpxY, with putative regulatory function on capsule expression in group B streptococci, FEMS Immunology and Medical Microbiology, 1998, pp. 159-168, vol. 21.
McNab, Cloning and sequence analysis of thymidine kinase from the oral bacteriumStreptococcus gordonii, FEMS Microbiology Letters, 1996, pp. 103-110, vol. 135.
Munoz et al., Characterization of IS1515, a Functional Insertion Sequence inStreptococcus pneumoniae, Journal of Bacteriology, Mar. 1998, pp. 1381-1388, vol. 180, No. 6.
Segers et al., Characterization of the gene encoding suilysin fromStreptococcus suisand expression in field strains, FEMS Microbiology Letters, 1998, pp. 255-261, vol. 167.
Smith et al., Environmentally regulated genes ofStreptococcus suis: identification by the use of iron-restricted conditions in vitro and experimental infections of piglets, Microbiology, 2001, pp. 271-280, vol. 147.
Smith et al., Mutants ofStreptococcus suisTypes 1 and 2 Impaired in Expression of Muramidase-Released Protein and Extracellular Protein Induce Disease in Newborn Germfree Pigs, Infection and Immunity, Oct. 1996, pp. 4409-4412, vol. 64, No. 10.
Dutch Text Annual Report ID-DLOStreptococcus Suis, 1996, with English translation of said report.

Affiliated with

Also associated with

Rating

Streptococcus suis vaccines and diagnostic tests does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Streptococcus suis vaccines and diagnostic tests, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Streptococcus suis vaccines and diagnostic tests will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3668787